Market Overview:

The global Seasonal Influenza Vaccine Market is forecast to grow significantly, reaching a valuation of $13.63 billion by 2030, with a compound annual growth rate (CAGR) of 9.5% during 2024-2030, according to the latest report by IndustryARC. The market's growth is fueled by advancements in vaccine technologies, increasing demand for quadrivalent vaccines, and robust government initiatives promoting public health.

Regional Insights:

North America leads the market with high vaccination rates, robust healthcare infrastructure, and government support. Europe prioritizes universal vaccination policies and pandemic preparedness, driven by the UK, Germany, and France. APAC shows rapid growth, led by China, India, and Japan, due to rising healthcare awareness and immunization efforts in developing nations. South America intensifies vaccination campaigns, with Brazil and Argentina at the forefront. The Middle East and Africa focus on enhancing immunization through government initiatives, despite logistical challenges.

For More Queries About " Seasonal Influenza Vaccine " @ https://www.industryarc.com/pdfdownload.php?id=501700

Scope of the Report:

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

9.5%

Market Size in 2030

$13.63 Billion

Segments Covered

Product Type, Influenza Type, Age Group, Valency, Distribution Channel and Region

Geographies Covered

North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Market Players

1.        GSK plc

2.       Sanofi S.A.

3.       AstraZeneca plc

4.       CSL Limited

5.       BIKEN Co., Ltd.

6.       Abbott Laboratories

7.       SINOVAC Biotech Ltd.

8.       Viatris Inc.

9.       Novartis Ag

10.   Moderna, Inc.


Seasonal Influenza Vaccine Market: Competitive Landscape

The Seasonal Influenza Vaccine market is competitive, with key players focusing on product innovation, strategic partnerships, and geographical expansion. Major companies include: GSK plc, Sanofi S.A., AstraZeneca plc, CSL Limited, BIKEN Co., Ltd., Abbott Laboratories, SINOVAC Biotech Ltd., Viatris Inc., Novartis AG, and Moderna, Inc.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.


Contact Us:

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 518-282-4727